Protocol #547-SSE-201: An Open-Label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of SAGE-547 Injection as Adjunctive Therapy in the Treatment of Adults with Super-Refractory Status Epilepticus

Project: Research project

Project Details

StatusFinished
Effective start/end date6/24/146/24/17

Funding

  • MS Clinical Services, LLC (547-SSE-201 // 547-SSE-201)
  • Sage Therapeutics, Inc. (547-SSE-201 // 547-SSE-201)